13F Data
13F filer · CIK 1831423

Vida Ventures Advisors, LLC

BOSTON, MA · filing since Q3 2020 · last filing Nov 3, 2025
Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022
Reported value
$29.4M
+$13.5M vs prior
Positions
2
New / sold out
0 / 0
Added / reduced
0 / 0
Turnover
0.0%
buys $0 · sells $0
Top-10 weight
100.0%

Biggest buys vs Q2 2025

No new or increased positions this quarter.

Biggest sells vs Q2 2025

No reduced or sold positions this quarter.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q3 2020: $159.7MQ4 2020: $487.2MQ1 2021: $395.8MQ2 2021: $398.8MQ3 2021: $349.2MQ4 2021: $267.3MQ1 2022: $171.9MQ2 2022: $118.3MQ3 2022: $111.4MQ4 2022: $74.4MQ1 2023: $73.1MQ2 2023: $76.6MQ3 2023: $64.6MQ4 2023: $84.0MQ1 2024: $180.0MQ2 2024: $91.4MQ3 2024: $138.6MQ4 2024: $146.3MQ1 2025: $13.6MQ2 2025: $15.9MQ3 2025: $29.4M
Q3 2020Q3 2025

Holdings · Q3 2025

#SecuritySharesValueWeight
1KYVERNA THERAPEUTICS INCCOM4,523,924$27.1M92.41%
2ALLOGENE THERAPEUTICS INCCOM1,798,163$2.2M7.59%